Original title: UK clinical guideline for the prevention and treatment of osteoporosis
Osteoporosis weakens bones and raises the chance of fractures. This UK guideline gives healthcare professionals recommendations for assessing bone health and fracture risk, then choosing ways to prevent or manage fractures. It covers medicines and non-drug approaches, including how long some treatments should continue and how they should be monitored. The recommendations draw on research evidence and are graded by how strong that evidence is.
Imagine checking a house for weak spots before deciding what repairs it needs. The hard part is judging which problems are serious enough to act on, and then choosing repairs and checking whether they are working. In this paper, the house is a person's bones, the inspection is the assessment of fracture risk, and the repair plan is the guideline's advice on prevention, treatment and follow-up.
Osteoporosis can lead to fragility fractures, so decisions about assessing risk and preventing fractures affect patients and the healthcare professionals who care for them. This UK guideline brings evidence-based recommendations together, including advice on treatment, follow-up and how fracture-prevention services can be organised.
The abstract describes the guideline's scope and evidence methods, but does not give the specific recommendations, the evidence grades, or details of how individual treatments compare. It also does not report patient outcomes or establish how well the recommendations work in practice.
Ask anything about this paper. Answers come from its abstract, and say so when the abstract doesn't cover your question.
UK clinical guideline for the prevention and treatment of osteoporosis — Celia Louise Gregson, David Armstrong, Jean Bowden et al. — Archives of Osteoporosis — doi:10.1007/s11657-022-01061-5
Abstract licence: CC BY
Explanation generated by Synthesis from the abstract — it is not the original paper.